UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 53.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 87,219 shares of the healthcare conglomerate’s stock after purchasing an additional 30,340 shares during the period. UnitedHealth Group comprises about 0.7% of Segall Bryant & Hamill LLC’s investment portfolio, making the stock its 19th biggest holding. Segall Bryant & Hamill LLC’s holdings in UnitedHealth Group were worth $50,995,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the third quarter worth $27,000. Macroview Investment Management LLC grew its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC bought a new position in UnitedHealth Group in the second quarter worth about $31,000. Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC grew its stake in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 2.2 %

NYSE:UNH opened at $576.93 on Wednesday. The stock’s 50 day moving average price is $582.31 and its 200 day moving average price is $551.25. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market capitalization of $530.94 billion, a P/E ratio of 37.59, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 EPS. The firm’s revenue was up 9.2% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on UNH shares. Stephens cut their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and set a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Cantor Fitzgerald upped their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.